Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
1 infec 91 - tabish60102
#1
A 45-year-old man is evaluated because of culture-proven herpes simplex virus infection of the face that has been progressing despite high doses of intravenous acyclovir (10 mg/kg every 8 hours). The patient underwent hematopoietic stem cell transplantation 2 months ago and receives three immunosuppressive drugs at maximal doses. He has had recurrent herpes labialis infections since childhood.

On physical examination, he is in no apparent distress. Umbilicated vesicular lesions with raised and erythematous edges are present on his right cheek. No pustules are seen. The leukocyte count is 1500/μL (1.5 × 109/L), serum creatinine is 2.5 mg/dL (221.05 µmol/L), and serum electrolytes are normal.

Which of the following antiviral agents is most appropriate at this time?

A Valacyclovir
B Famciclovir
] C Ganciclovir
] D Foscarnet
E Cidofovir
Reply
#2
no clue,,,,will go for E...Cidofovir
Reply
#3
DD. resistance to acyclovir, should try Foscarnet.
Reply
#4
Correct Answer = D)
Key Points

* Administration of foscarnet is indicated for a patient with acyclovir-resistant herpes simplex virus infection.
* Administration of foscarnet may be associated with significant electrolyte abnormalities.

This patient has clinical evidence of an acyclovir-resistant herpes simplex virus infection. Although the dose of acyclovir is higher than normally used for treatment of cutaneous herpes simplex virus infections, there is no evidence of healing. He should therefore be started on foscarnet, which is a pyrophosphate analogue that binds to viral DNA and has a different mechanism of action than the other medications listed. Because administration of foscarnet can cause significant electrolyte abnormalities, routine laboratory studies are indicated before beginning this drug.

Valacyclovir, famciclovir, and ganciclovir should not be used because all three drugs show cross resistance in clinical circumstances such as these. Cidofovir may also be used in the treatment of acyclovir-resistant herpes simplex virus infection. However, cidofovir would not be the initial drug of choice because it is associated with nephrotoxicity and would exacerbate the patient's renal dysfunction.
Bibliography
Reply
« Next Oldest | Next Newest »


Forum Jump: